Showing 1 - 17 results of 17 for search 'Eva Brand', query time: 0.05s
Refine Results
-
1
Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease by Malte Lenders, Eva Brand
Published 2022-12-01
Article -
2
In Vitro and In Vivo Amenability to Migalastat in Fabry Disease by Malte Lenders, Franciska Stappers, Eva Brand
Published 2020-12-01
Article -
3
Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa by Malte Lenders, Solvey Pollmann, Melina Terlinden, Eva Brand
Published 2022-09-01
Article -
4
Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact? by Malte Lenders, Boris Schmitz, Stefan-Martin Brand, Eva Brand
Published 2018-09-01
Article -
5
Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation by Solvey Pollmann, David Scharnetzki, Dominique Manikowski, Malte Lenders, Eva Brand
Published 2021-11-01
Article -
6
-
7
-
8
-
9
-
10
-
11
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease by Christian Pogoda, Stefan-Martin Brand, Thomas Duning, Thomas Duning, Antje Schmidt-Pogoda, Jürgen Sindermann, Malte Lenders, Eva Brand
Published 2023-11-01
Article -
12
-
13
-
14
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry). by Holger Reinecke, Günter Breithardt, Christiane Engelbertz, Roland E Schmieder, Manfred Fobker, Hans O Pinnschmidt, Boris Schmitz, Philipp Bruland, Karl Wegscheider, Hermann Pavenstädt, Eva Brand
Published 2016-01-01
Article -
15
Alcohol intake modulates the genetic association between HDL cholesterol and the PPARγ2 Pro12Ala polymorphism by Stefan-Martin Brand-Herrmann, Tatiana Kuznetsova, Andreas Wiechert, Katarzyna Stolarz, Valerie Tikhonoff, Klaus Schmidt-Petersen, Ralph Telgmann, Edoardo Casiglia, Ji-Guang Wang, Lutgarde Thijs, Jan A. Staessen, Eva Brand
Published 2005-05-01
Article -
16
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease by Sanne J. van der Veen, Wytze J. Vlietstra, Laura van Dussen, André B.P. van Kuilenburg, Marcel G. W. Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M. Elliott, Carla E. M. Hollak, Mirjam Langeveld
Published 2020-08-01
Article -
17
Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis by Christoph Wanner, Ulla Feldt‐Rasmussen, Ana Jovanovic, Aleš Linhart, Meng Yang, Elvira Ponce, Eva Brand, Dominique P. Germain, Derralynn A. Hughes, John L. Jefferies, Ana Maria Martins, Albina Nowak, Bojan Vujkovac, Frank Weidemann, Michael L. West, Alberto Ortiz
Published 2020-06-01
Article